Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses
General and administrative	$ 2,767,866	$ 6,470,405
Research and development	1,958,714	157,952
Depreciation and amortization	69,265	136,640
Total operating expenses	4,795,845	6,764,997
Loss from operations	(4,795,845)	(6,764,997)
Other income (expense)
Inducement expense		(298,714)
Change in fair value of warrant liabilities	275,969	3,813,000
Interest expense	(4,138)
Total other income	271,831	3,514,286
Net loss	(4,524,014)	(3,250,711)
Other comprehensive gain
Foreign currency translation	88,709	35,736
Comprehensive loss	$ (4,435,305)	$ (3,214,975)
Net loss per share - basic and diluted	$ (0.11)	$ (0.20)
Weighted average shares outstanding, basic and diluted	42,356,752	16,220,661